News

Mary’s Healing Heart has a significantly higher Cannabidiol (CBD) level and lower THC level than the most well known high-CBD strains available today. A recent media blitz has

Every October, CADCA urges its membership to plan and promote an educational event – such as town hall meetings for parents, youth, and local advocates – to educate

"The microbiome is an important area of medical research for Mayo Clinic, and this collaboration represents a broad and significant effort in our attempt to develop therapeutics targeting

Achieve Nutrition Systems CEO Amanda Halliday said, "Partnering with Game Plan was the perfect fit for Achieve Nutrition Systems. We are always on the look-out for new revenue

The global, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial will evaluate disease remission in these patients treated with subcutaneous ofatumumab as add-on treatment to oral steroids. In Pemphigus vulgaris,

In 2008, Humira was approved in the US for polyarticular juvenile idiopathic arthritis (JIA) in patients aged four years and older. AbbVie Pharmaceutical Development vice-president Scott Brun said

GA is the severe stage of the dry form of age-related macular degeneration (dry-AMD). OpRegen includes retinal pigment epithelial (RPE) cells derived from human embryonic stem cells and

ARIAD will receive $50 million in exchange for a fully paid up license to this technology and return of its equity stake in closely held Bellicum. The scope

If the merger deal was successful, Salix would have been combined with, and become a wholly-owned subsidiary of, Cosmo Technologies, a subsidiary of Cosmo. As part of the